(20α)-17α-Methoxy-18β-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16β-carboxylic acid methyl ester (482-87-1)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- (3β,20α)-17α-Ethyl-11-methoxy-18β-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16β-carboxylic acid methyl ester
- (3β,20α)-1,2-Didehydro-2,7-dihydro-11,17α-dimethoxy-18β-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16β-carboxylic acid methyl ester
- (3β,20α)-11,17α-Dimethoxy-18β-[(3,5-dimethoxy-4-isopropylbenzoyl)oxy]yohimban-16β-carboxylic acid methyl ester
- (3β,20α)-11,17α-Dimethoxy-18β-[(3,5-diethoxy-4-methoxybenzoyl)oxy]yohimban-16β-carboxylic acid methyl ester
- (3β,20α)-11,17α-Dimethoxy-18β-[[3,5-dimethoxy-4-(sec-butyl)benzoyl]oxy]yohimban-16β-carboxylic acid methyl ester
- (3β,20α)-11,17α-Dimethoxy-18β-[(tetrahydro-2H-pyran-2-yl)oxy]yohimban-16β-carboxylic acid methyl ester
- 18β-Hydroxy-11,17α-diMethoxy-3β,20α-yohiMban-16β-carboxylic Acid Methyl, p-BroMobenzenesulfonate Ester
- (20α)-18β-(3,4,5-Trimethoxybenzoyloxy)-11,17α-dimethoxy-3,4-secoyohimban-16β-carboxylic acid methyl ester
- (3β,20α)-18β-Hydroxy-11,17α-dimethoxyyohimban-16β-carboxylic acid 4-oxide
- Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3b,20a)- (9CI)
- Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-18-[(3,4,5- trimethoxybenzoyl)oxy]-,methyl ester,(3â,16â,17R,18â,20R)-
- 17α-Hydroxy-10-methoxyyohimban-16β-carboxylic acid methyl ester
- (3β)-17α-Hydroxyyohimban-16β-carboxylic acid methyl ester
- Yohimban-16-carboxylic acid,11,17-dimethoxy-12-nitro-18-[(3,4,5- trimethoxybenzoyl)oxy]-,methyl ester,(3â,16â,17R,18â,20R)-
- Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 4-chloro-N(1)-methyl-N(1)-((tetrahydro-2-methyl-2-furanyl)methyl)-1,3-benzenedisulfonamide and 3-hydroxy-alpha-methyl-L-tyrosine
- Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 4-chloro-N(1)-methyl-N(1)-((tetrahydro-2-methyl-2-furanyl)methyl)-1,3-benzenedisulfonamide and myo-inositol hexa-3-pyridinecarboxylate
- Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3β,16β,17α,18β,20α)-, mono[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodobenzeneacetate]
- Yohimban-16-carboxylic acid, 1-[2-(diethylamino)ethyl]-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3β,16β,17α,18β,20α)-, compd. with 5-oxo-l-proline (1:2)
- Yohimban-16-carboxylicacid, 17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3b,16b,17a,18b,20a)-
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with rel-3-(aminosulfonyl)-4-chloro-N-[(2R,6S)- 2,6-dimethyl-1-piperidinyl]benzamide and (5'R)-12'-hydroxy-2'-(1-methylethyl)-5'- (phenylmethyl)ergotaman-3',6',18-trione monomethanesulfonate (salt)
